IP Library Granted Patent US 9,173,735
Granted Patent B2
US 9,173,735 · App. 14/282,959 · Granted Nov 3, 2015

Porous ureteral stent

Inventors: Hamid Davoudi (Westwood, MA); Alfred P. Intoccia, Jr. (Nashua, NH); Jianmin Li (Lexington, MA)
Assignee: Boston Scientific Scimed, Inc.
A61F2/04A61M25/00A61M27/008A61F2002/048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,173,735
App. No.
14/282,959
Granted
Nov 3, 2015
Kind
B2
Abstract

In some embodiments, a stent includes an elongate member and a distal retention member. The elongate member is configured to be disposed within a ureter of a patient and has a first portion, a second portion and a plurality of beads bonded together. The plurality of beads define a plurality of spaces between the plurality of beads. The plurality of spaces are configured to allow fluid to flow from the first portion of the elongate member to the second portion of the elongate member. The distal retention member is configured to help maintain a portion of the stent within a kidney of the patient.

Claims (18)

1. A stent comprising:

an elongate member having a distal end portion, a proximal end portion and a plurality of beads, the elongate member defining a longitudinal axis, each bead of the plurality of beads has a first portion and a second portion, the first portion of each of the plurality of beads defines a lumen, the second portion the first bead of the plurality of beads defines a lumen and the second portion of the second bead of the plurality of beads defines a lumen, the lumen defined by the second portion of the second bead is offset from the lumen defined by the second portion of the first bead.

2. The stent of claim 1 , wherein the plurality of beads are substantially figure eight shaped.

3. The stent of claim 1 , further comprising:

a proximal retention member configured to help maintain a portion of the stent within a bladder of a patient, the proximal retention member including a plurality of beads.

4. The stent of claim 1 , wherein the second portion of the first bead of the plurality of beads does not contact the second portion of the second bead of the plurality of beads, the first bead being adjacent the second bead.

5. The stent of claim 1 , wherein the first portion of the first bead of the plurality of beads is coupled to the first portion of the second bead of the plurality of beads.

6. The stent of claim 1 , wherein the first portion of the first bead of the plurality of beads does not contact the first portion of the second bead of the plurality of beads, the first bead being adjacent the second bead.

7. A stent comprising:

an elongate member configured to extend from a kidney to a bladder of a patient, the elongate member including a first material and a second material, the second material formulated to dissolve when the stent is disposed within a urinary tract of the patient for a predetermined amount of time, the stent being softer after the second material dissolves, the second material being a crystallized salt.

8. The stent of claim 7 , wherein the second material has a high solubility in aqueous solutions.

9. The stent of claim 7 , wherein the second material is formulated to lower the pH of urine when dissolved within the urinary tract of the patient.

10. The stent of claim 7 , wherein the second material is formulated to promote wound healing when dissolved adjacent to a wound of the patient.

11. The stent of claim 7 , further comprising:

a distal retention member including the first material and the second material, the distal retention member configured to move from a first configuration to a second configuration when the stent is disposed within the urinary tract of the patient for the predetermined amount of time,

the distal retention member configured to help maintain a portion of the stent within the kidney of the patient when in the first configuration,

the distal retention member configured to allow the stent migrate from the kidney of the patient to the bladder of the patient when in the second configuration.

12. The stent of claim 7 , wherein the second material is interspersed within the first material before dissolving.

Continuity (4)
Continuation 13488075 · Jun 4, 2012
Continuation 12567367 · Sep 25, 2009
Provisional Application 61120109 · Dec 5, 2008
Related Publication 20140257511A1 · Sep 11, 2014